Literature DB >> 9506831

A de novo missense mutation of human cardiac Na+ channel exhibiting novel molecular mechanisms of long QT syndrome.

N Makita1, N Shirai, M Nagashima, R Matsuoka, Y Yamada, N Tohse, A Kitabatake.   

Abstract

Mutations in a human cardiac Na+ channel gene (SCN5A) are responsible for chromosome 3-linked congenital long QT syndrome (LQT3). Here we characterized a de novo missense mutation (R1623Q, S4 segment of domain 4) identified in an infant Japanese girl with a severe form of LQT3. When expressed in oocytes, mutant Na+ channels exhibited only minor abnormalities in channel activation, but in contrast to three previously characterized LQT3 mutations, had significantly delayed macroscopic inactivation. Single channel analysis revealed that R1623Q channels have significantly prolonged open times with bursting behavior, suggesting a novel mechanism of pathophysiology in Na+ channel-linked long QT syndrome.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9506831     DOI: 10.1016/s0014-5793(98)00033-7

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  12 in total

1.  Sodium channel carboxyl-terminal residue regulates fast inactivation.

Authors:  Hai M Nguyen; Alan L Goldin
Journal:  J Biol Chem       Date:  2010-01-20       Impact factor: 5.157

2.  A revised view of cardiac sodium channel "blockade" in the long-QT syndrome.

Authors:  N G Kambouris; H B Nuss; D C Johns; E Marbán; G F Tomaselli; J R Balser
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

3.  Reduced voltage sensitivity of activation of P/Q-type Ca2+ channels is associated with the ataxic mouse mutation rolling Nagoya (tg(rol)).

Authors:  Y Mori; M Wakamori; S Oda; C F Fletcher; N Sekiguchi; E Mori; N G Copeland; N A Jenkins; K Matsushita; Z Matsuyama; K Imoto
Journal:  J Neurosci       Date:  2000-08-01       Impact factor: 6.167

4.  Novel SCN5A mutation in amiodarone-responsive multifocal ventricular ectopy-associated cardiomyopathy.

Authors:  Thomas M Beckermann; Karen McLeod; Victoria Murday; Franck Potet; Alfred L George
Journal:  Heart Rhythm       Date:  2014-05-09       Impact factor: 6.343

5.  Use-dependent block of cardiac late Na(+) current by ranolazine.

Authors:  Sridharan Rajamani; Nesrine El-Bizri; John C Shryock; Jonathan C Makielski; Luiz Belardinelli
Journal:  Heart Rhythm       Date:  2009-07-28       Impact factor: 6.343

6.  Differential modulation of late sodium current by protein kinase A in R1623Q mutant of LQT3.

Authors:  Takuo Tsurugi; Toshihisa Nagatomo; Haruhiko Abe; Yasushi Oginosawa; Hiroko Takemasa; Ritsuko Kohno; Naomasa Makita; Jonathan C Makielski; Yutaka Otsuji
Journal:  Life Sci       Date:  2009-01-09       Impact factor: 5.037

7.  Congenital sick sinus syndrome caused by recessive mutations in the cardiac sodium channel gene (SCN5A).

Authors:  D Woodrow Benson; Dao W Wang; Macaira Dyment; Timothy K Knilans; Frank A Fish; Margaret J Strieper; Thomas H Rhodes; Alfred L George
Journal:  J Clin Invest       Date:  2003-10       Impact factor: 14.808

8.  Pathophysiological role of omega pore current in channelopathies.

Authors:  Karin Jurkat-Rott; James Groome; Frank Lehmann-Horn
Journal:  Front Pharmacol       Date:  2012-06-11       Impact factor: 5.810

9.  Single-channel properties of human NaV1.1 and mechanism of channel dysfunction in SCN1A-associated epilepsy.

Authors:  Carlos G Vanoye; Christoph Lossin; Thomas H Rhodes; Alfred L George
Journal:  J Gen Physiol       Date:  2006-01       Impact factor: 4.086

Review 10.  Physiological and Pathophysiological Insights of Nav1.4 and Nav1.5 Comparison.

Authors:  Gildas Loussouarn; Damien Sternberg; Sophie Nicole; Céline Marionneau; Francoise Le Bouffant; Gilles Toumaniantz; Julien Barc; Olfat A Malak; Véronique Fressart; Yann Péréon; Isabelle Baró; Flavien Charpentier
Journal:  Front Pharmacol       Date:  2016-01-14       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.